A clinical trial with 149 patients suffering from systemic lupus, has shown the effectiveness of a synthetic peptide developed by a team of researchers led by CNRS biologist Slyviane Muller at the Institut de Biologie Moleculaire (IBMC) in Strasbourg, France.
University of Louisville School of Medicine Researchers identify gene variants that may cause kidney problems in lupus patients
Researchers unravel how DNA damage may trigger lupus erythematosus
RCSI Researcher finds Irish Lupus patients likely to benefit from new treatment
Takeda And Resolve Therapeutics To Develop Lupus Treatments
Osaka-based Takeda Pharmaceutical Company Limited and U.S. biotech Resolve Therapeutics, LLC have entered into a partnership to develop compounds for the treatment of lupus and other autoimmune diseases.
Does Lupus Increase Risk of Psychiatric Issues?
Despite more than half of the cohort taking vitamin D supplements, 58% of Thai patients with SLE had vitamin D deficiency or insufficiency...
Researchers in Thailand conducted a cross-sectional study of 101 patients with systemic lupus erythematosus (SLE; mean age, 40.13 years; 96% women). Blood samples were collected and stored. Radioimmunoassay was used to measure levels of serum 25(OH) vitamin D (25[OH]D). Vitamin D deficiency and insufficiency were considered at 30 ng/mL and 20 ng/mL, respectively. After demographic, clinical and laboratory data were collected, univariate and multivariate linear regression analyses were used to examine their associations with 25(OH)D level.
Despite its prevalence, leukopenia typically was not persistent or a risk factor for severe infection among patients with SLE, according to recent study results by researchers in Thailand.
Despite its prevalence, leukopenia typically was not persistent or a risk factor for severe infection among patients with SLE, according to recent study results by researchers in Thailand.
Steroids, older age worsen Lupus damage.
More sleep problems for patients with SLE
Patients with SLE had more sleep problems than the general US population, and psychosocial factors, particularly depression and anxiety, were associated with the abnormalities, according to recent study results from the University of Chicago Rheumatology clinic.
Test drug delivery system - early promise for improved treatment of lupus and other autoimmune diseases
Hospital for Special Surgery, New York City receives grant for new genomics center to study autoimmune diseases.
Lupus - greater risk factor for heart disease than smoking
Concerns about long-term steroid use
A second clinical trial of abatacept has failed to demonstrate improved outcomes in patients with lupus nephritis.
Researchers have found a link between the hormone, estrogen and the development of the disease.
SLU Researchers Win NIH Grant to Study Lupus
ST. LOUIS - Two researchers at Saint Louis University's division of rheumatology in the department of internal medicine have been awarded a $1.8 million NIH grant to study the physiological and biochemical functions in lupus, an autoimmune disease, and develop possible new medications for its treatment...
